about us


Excelimmune is driven to develop complex antibody-based therapeutics. While we are committed to creating our own pipeline of Antibody Combination Therapeutics (ACT), we are actively seeking strategic collaborations with partners in the U.S., Europe, and Japan.

For more information, please contact us using the form to the right or call us at 781-262-8055.